Research Historical Balance Sheet

REFR Stock

USD 1.83 0.01 0.55%

Trend analysis of Research Frontiers Incorporated balance sheet accounts such as Cash of 3.8 M, Non Current Assets Total of 437.8 K, Non Currrent Assets Other of 91.2 K or Cash And Short Term Investments of 2.4 M provides information on Research Frontiers' total assets, liabilities, and equity, which is the actual value of Research Frontiers to its prevalent stockholders. By breaking down trends over time using Research Frontiers balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Research Frontiers latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Research Frontiers is a good buy for the upcoming year.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Research Frontiers Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

About Research Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Research Frontiers at a specified time, usually calculated after every quarter, six months, or one year. Research Frontiers Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Research Frontiers and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Research currently owns. An asset can also be divided into two categories, current and non-current.

Research Frontiers Balance Sheet Chart

At this time, Research Frontiers' Liabilities And Stockholders Equity is relatively stable compared to the past year. As of 12/15/2024, Total Liabilities is likely to grow to about 497.2 K, while Net Debt is likely to drop (2.3 M).

Total Assets Total Current Liabilities Total Stockholder Equity Property Plant And Equipment Net Net Tangible Assets

Add Fundamental

Total Assets

Total assets refers to the total amount of Research Frontiers assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Research Frontiers books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Research Frontiers balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Research Frontiers Incorporated are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Most accounts from Research Frontiers' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Research Frontiers current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Research Frontiers Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

	2021	2022	2023	2024 (projected)
Total Stockholder Equity	3.8M	4.8M	3.5M	6.8M
Total Current Liabilities	297.9K	301.9K	277.4K	300.0K

Total Stockholder Equity Total Current Liabilities

Research Frontiers balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Total	Other Current Assets	Accounts Payable	Net Receivables	Short Term Investments	Other Assets	Common Stock Total Equity	Common Stock	Property Plant Equipment	Current Deferred Revenue
Total Assets		-0.01	-0.21	1.0	0.03	-0.88	-0.04	0.89	0.31	-0.36	0.95	-0.02	0.16	-0.24	-0.27	0.99	-0.2	-0.18	-0.28	-0.24	0.66	-0.07	-0.12	-0.07	-0.02	-0.17
Other Current Liab	-0.01		0.78	-0.01	0.12	-0.16	0.65	0.03	0.24	0.09	0.04	-0.59	-0.46	-0.05	-0.65	-0.05	-0.28	0.53	0.56	0.63	0.06	-0.31	-0.64	-0.65	0.66	-0.02
Total Current Liabilities	-0.21	0.78		-0.23	0.22	-0.01	0.54	-0.05	0.38	0.41	-0.23	-0.48	-0.5	0.32	-0.23	-0.28	-0.01	0.52	0.65	0.67	-0.33	-0.31	-0.42	-0.43	0.56	-0.02
Total Stockholder Equity	1.0	-0.01	-0.23		-0.01	-0.87	-0.03	0.87	0.28	-0.36	0.95	-0.04	0.15	-0.31	-0.27	0.99	-0.27	-0.17	-0.28	-0.23	0.69	-0.1	-0.14	-0.1	-0.02	-0.2
Property Plant And Equipment Net	0.03	0.12	0.22	-0.01		-0.05	-0.43	0.11	0.7	-0.22	-0.08	0.48	0.47	0.56	0.1	-0.07	0.49	-0.33	-0.29	-0.23	-0.39	0.3	0.38	0.45	0.55	-0.21
Net Debt	-0.88	-0.16	-0.01	-0.87	-0.05		-0.11	-0.98	-0.33	0.3	-0.9	0.07	-0.09	0.11	0.45	-0.87	0.1	0.11	0.08	0.08	-0.43	0.0	0.15	0.11	0.09	0.18
Retained Earnings	-0.04	0.65	0.54	-0.03	-0.43	-0.11		0.03	-0.21	0.42	0.09	-0.88	-0.89	-0.18	-0.53	-0.01	-0.31	0.9	0.9	0.89	0.26	-0.21	-0.81	-0.85	0.06	0.26
Cash	0.89	0.03	-0.05	0.87	0.11	-0.98	0.03		0.35	-0.23	0.87	-0.03	0.1	-0.01	-0.34	0.87	0.0	-0.17	-0.12	-0.13	0.36	0.07	-0.09	-0.03	-0.16	-0.2
Non Current Assets Total	0.31	0.24	0.38	0.28	0.7	-0.33	-0.21	0.35		-0.14	0.15	0.22	0.26	0.27	0.0	0.17	0.12	-0.21	-0.14	-0.09	-0.22	0.11	0.13	0.18	0.56	-0.3
Non Currrent Assets Other	-0.36	0.09	0.41	-0.36	-0.22	0.3	0.42	-0.23	-0.14		-0.46	-0.51	-0.72	0.09	0.37	-0.36	-0.09	0.55	0.66	0.64	-0.38	-0.06	-0.29	-0.31	-0.13	-0.1
Cash And Short Term Investments	0.95	0.04	-0.23	0.95	-0.08	-0.9	0.09	0.87	0.15	-0.46		-0.03	0.14	-0.25	-0.41	0.96	-0.16	-0.08	-0.18	-0.15	0.76	-0.07	-0.13	-0.1	-0.09	-0.02
Common Stock Shares Outstanding	-0.02	-0.59	-0.48	-0.04	0.48	0.07	-0.88	-0.03	0.22	-0.51	-0.03		0.94	0.3	0.47	-0.05	0.48	-0.75	-0.74	-0.72	-0.22	0.3	0.95	0.97	-0.05	-0.09
Other Stockholder Equity	0.16	-0.46	-0.5	0.15	0.47	-0.09	-0.89	0.1	0.26	-0.72	0.14	0.94		0.14	0.26	0.13	0.31	-0.84	-0.87	-0.83	-0.06	0.19	0.81	0.84	0.05	-0.16
Total Liab	-0.24	-0.05	0.32	-0.31	0.56	0.11	-0.18	-0.01	0.27	0.09	-0.25	0.3	0.14		0.12	-0.29	0.93	-0.1	0.11	0.01	-0.5	0.32	0.35	0.42	0.0	0.38
Property Plant And Equipment Gross	-0.27	-0.65	-0.23	-0.27	0.1	0.45	-0.53	-0.34	0.0	0.37	-0.41	0.47	0.26	0.12		-0.28	0.14	-0.25	-0.26	-0.24	-0.32	-0.02	0.62	0.6	-0.13	-0.24
Total Current Assets	0.99	-0.05	-0.28	0.99	-0.07	-0.87	-0.01	0.87	0.17	-0.36	0.96	-0.05	0.13	-0.29	-0.28		-0.22	-0.16	-0.27	-0.23	0.72	-0.09	-0.14	-0.1	-0.11	-0.13
Non Current Liabilities Total	-0.2	-0.28	-0.01	-0.27	0.49	0.1	-0.31	0.0	0.12	-0.09	-0.16	0.48	0.31	0.93	0.14	-0.22		-0.21	-0.05	-0.16	-0.36	0.45	0.51	0.58	-0.2	0.47
Other Current Assets	-0.18	0.53	0.52	-0.17	-0.33	0.11	0.9	-0.17	-0.21	0.55	-0.08	-0.75	-0.84	-0.1	-0.25	-0.16	-0.21		0.91	0.93	0.21	-0.12	-0.62	-0.67	0.12	0.28
Accounts Payable	-0.28	0.56	0.65	-0.28	-0.29	0.08	0.9	-0.12	-0.14	0.66	-0.18	-0.74	-0.87	0.11	-0.26	-0.27	-0.05	0.91		0.97	-0.03	-0.13	-0.58	-0.63	0.05	0.27
Net Receivables	-0.24	0.63	0.67	-0.23	-0.23	0.08	0.89	-0.13	-0.09	0.64	-0.15	-0.72	-0.83	0.01	-0.24	-0.23	-0.16	0.93	0.97		0.02	-0.14	-0.56	-0.62	0.19	0.2
Short Term Investments	0.66	0.06	-0.33	0.69	-0.39	-0.43	0.26	0.36	-0.22	-0.38	0.76	-0.22	-0.06	-0.5	-0.32	0.72	-0.36	0.21	-0.03	0.02		-0.26	-0.29	-0.3	-0.01	0.22
Other Assets	-0.07	-0.31	-0.31	-0.1	0.3	0.0	-0.21	0.07	0.11	-0.06	-0.07	0.3	0.19	0.32	-0.02	-0.09	0.45	-0.12	-0.13	-0.14	-0.26		0.28	0.33	-0.21	0.38
Common Stock Total Equity	-0.12	-0.64	-0.42	-0.14	0.38	0.15	-0.81	-0.09	0.13	-0.29	-0.13	0.95	0.81	0.35	0.62	-0.14	0.51	-0.62	-0.58	-0.56	-0.29	0.28		0.98	-0.15	-0.06
Common Stock	-0.07	-0.65	-0.43	-0.1	0.45	0.11	-0.85	-0.03	0.18	-0.31	-0.1	0.97	0.84	0.42	0.6	-0.1	0.58	-0.67	-0.63	-0.62	-0.3	0.33	0.98		-0.15	-0.06
Property Plant Equipment	-0.02	0.66	0.56	-0.02	0.55	0.09	0.06	-0.16	0.56	-0.13	-0.09	-0.05	0.05	0.0	-0.13	-0.11	-0.2	0.12	0.05	0.19	-0.01	-0.21	-0.15	-0.15		-0.15
Current Deferred Revenue	-0.17	-0.02	-0.02	-0.2	-0.21	0.18	0.26	-0.2	-0.3	-0.1	-0.02	-0.09	-0.16	0.38	-0.24	-0.13	0.47	0.28	0.27	0.2	0.22	0.38	-0.06	-0.06	-0.15

Click cells to compare fundamentals

Research Frontiers Account Relationship Matchups

Research Frontiers balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	8.3M	6.2M	4.5M	5.4M	3.9M	7.2M
Other Current Liab	46.7K	(140.1K)	(132.7K)	(162.0K)	(198.2K)	(188.3K)
Total Current Liabilities	387.4K	226.1K	297.9K	301.9K	277.4K	300.0K
Total Stockholder Equity	7.1M	5.3M	3.8M	4.8M	3.5M	6.8M
Property Plant And Equipment Net	915.7K	738.2K	562.8K	388.9K	218.3K	294.7K
Net Debt	(5.6M)	(4.0M)	376.3K	(3.8M)	(2.2M)	(2.3M)
Retained Earnings	(115.5M)	(117.8M)	(119.7M)	(122.4M)	(124.3M)	(118.1M)
Cash	6.6M	4.8M	270.0K	4.2M	2.5M	3.8M
Non Current Assets Total	949.3K	771.8K	596.3K	445.0K	274.4K	437.8K
Cash And Short Term Investments	6.6M	4.8M	3.0M	4.2M	2.5M	2.4M
Common Stock Shares Outstanding	30.0M	31.5M	31.6M	32.1M	33.5M	17.6M
Liabilities And Stockholders Equity	8.3M	6.2M	4.5M	5.4M	3.9M	7.2M
Other Stockholder Equity	122.6M	123.2M	123.5M	127.2M	127.8M	72.8M
Total Liab	1.2M	872.3K	762.1K	569.6K	332.8K	497.2K
Property Plant And Equipment Gross	915.7K	738.2K	3.3M	3.1M	3.0M	3.1M
Total Current Assets	7.3M	5.4M	3.9M	4.9M	3.6M	6.8M
Non Current Liabilities Total	812.6K	646.2K	464.1K	267.7K	55.4K	52.6K
Other Current Assets	58.8K	113.0K	185.9K	101.0K	96.8K	91.9K
Accounts Payable	169.8K	33.4K	66.5K	71.1K	50.9K	48.3K
Net Receivables	656.1K	598.3K	831.6K	589.6K	1.0M	527.4K
Common Stock Total Equity	2.8K	3.1K	3.2K	3.3K	3.8K	2.2K
Common Stock	3.1K	3.2K	3.2K	3.3K	3.4K	2.3K
Property Plant Equipment	141.7K	121.8K	562.8K	65.4K	75.2K	71.4K
Current Deferred Revenue	50.6K	7.7K	49.0K	1.0	1.15	1.09
Net Tangible Assets	7.1M	5.3M	3.8M	4.8M	4.3M	5.5M
Retained Earnings Total Equity	(111.7M)	(115.5M)	(117.8M)	(122.4M)	(110.1M)	(115.6M)
Capital Surpluse	114.8M	122.6M	123.2M	127.2M	146.2M	122.8M
Net Invested Capital	7.1M	5.3M	3.8M	4.8M	3.5M	4.7M
Net Working Capital	6.9M	5.2M	3.7M	4.6M	3.3M	4.6M
Capital Stock	3.1K	3.2K	3.2K	3.3K	3.4K	3.5K

Pair Trading with Research Frontiers

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Research Frontiers position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Research Frontiers will appreciate offsetting losses from the drop in the long position's value.

Moving against Research Stock

0.6	KULR	KULR Technology Group	Pair Corr
0.56	IONQ	IONQ Inc Upward Rally	Pair Corr
0.53	EXTR	Extreme Networks	Pair Corr
0.53	KODK	Eastman Kodak	Pair Corr
0.47	EHGO	Eshallgo Class A	Pair Corr

The ability to find closely correlated positions to Research Frontiers could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Research Frontiers when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Research Frontiers - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Research Frontiers Incorporated to buy it.

The correlation of Research Frontiers is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Research Frontiers moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Research Frontiers moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Research Frontiers can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Research Stock Analysis

When running Research Frontiers' price analysis, check to measure Research Frontiers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Research Frontiers is operating at the current time. Most of Research Frontiers' value examination focuses on studying past and present price action to predict the probability of Research Frontiers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Research Frontiers' price. Additionally, you may evaluate how the addition of Research Frontiers to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Research Historical Balance Sheet

About Research Balance Sheet Analysis

Research Frontiers Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Property Plant And Equipment Net

Net Tangible Assets

Research Frontiers balance sheet Correlations

Research Frontiers Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Research Frontiers balance sheet Accounts

Pair Trading with Research Frontiers

Moving against Research Stock

Additional Tools for Research Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Stockholder Equity
Common Stock	+ 0.98	Common Stock Total Equity
Common Stock	+ 0.97	Common Stock Shares Outstanding
Net Receivables	+ 0.97	Accounts Payable

Cash	- 0.98	Net Debt
Cash And Short Term Investments	- 0.9	Net Debt
Other Stockholder Equity	- 0.89	Retained Earnings
Common Stock Shares Outstanding	- 0.88	Retained Earnings
Net Debt	- 0.88	Total Assets
Accounts Payable	- 0.87	Other Stockholder Equity